Revvity
NYQ:RVTY · US7140461093
Life Sciences Tools & ServicesLarge
360
52
Value56
Quality58
Growth36
Safety44
Sentiment58
Value Creation10/20creating some value
- Creates more value than its capital costs
- Owner earnings growing
- Owner earnings per share growing
- Reinvests at strong returns
- Solid earnings base
What this means
Revvity clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.
Profile
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
TypePublic Company
ExchangeNYSE
Founded1947
Employees6,698
Websiterevvity.com
ISINUS7140461093
Last UpdateApr 2, 2026
Themes
Health DiagnosticsImmunologyStem Cell TherapyGeneticsBiomedical EngineeringGenetic DisorderOncologyInfectious Diseases
Description
Analysis
Middle-of-the-road
Revvity, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.
360° rank · history
1007550250
90
2023202420252026
All-time high
100
Mar 2026
All-time low
36
Jan 2024
Average rank
78
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.
Similar Stocks
The companies this stock is ranked against.
Cytek Biosciences
NSQ:CTKB
38
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Bio-Rad Laboratories
NYQ:BIO
48
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100